NCT04328337View on ClinicalTrials.gov

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Obesity
Interventions
DRUG

Intralipid, 20% Intravenous Emulsion

Infusion of Intralipid 20%

DRUG

Placebos

saline 30 ml/hr for 12 hours through an IV

Trial Locations (2)

27514

RECRUITING

Biomedical Research Imaging Center Marsico Hall (UNC), Chapel Hill

RECRUITING

Clinical and Translational Research Center (CTRC) Burnett-Womack Building (UNC), Chapel Hill

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of North Carolina, Chapel Hill

OTHER